( SAFE Credit Union Convention Center, Sacramento, USA | December 1–3, 2026 )
From December 1 to 3, 2026, Qingdao MacroAlga Co., Ltd. will attend the US Biostimulant Conference at the SAFE Credit Union Convention Center in Sacramento, USA, as a founding member of the Biostimulants Asia Alliance (BAA). At Booth D20, MacroAlga will present its pure enzymatic seaweed platform to the North American market and welcomes all formulators, distributors, and growers to meet the team in person.
This year’s event is a hybrid experience — live in person and digital. Meet us face to face in Sacramento, or connect with our team through the digital platform if you cannot travel. Please note that the workshops on November 30, 2026 require a separate ticket — see the conference website for registration details.
MacroAlga’s story began with a single enzyme. Working with the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT), Chinese Academy of Sciences, the company took alginate lyase from a laboratory result to a stable, industrial-scale enzyme — and built the entire seaweed business around it.
Today, every drop of MacroAlga’s seaweed extract is produced by self-produced enzymes — cellulase, alginate lyase, and fucoidanase — acting at 40–50 °C under near-neutral conditions. No acid. No alkali. No chemicals. The result is a fully soluble extract rich in defined low-DP oligosaccharides, with heat-sensitive actives preserved, a low salt load suited to foliar and drip application, and clean chelation of trace elements.
Four brown seaweeds run on one platform: fresh kelp received daily at the Gaomi plant, plus Ecklonia maxima, Ascophyllum nodosum, and Durvillaea potatorum on the dry-algae route. From pulping and enzymolysis to ceramic-membrane filtration and concentration, the whole seven-step process runs in-house — so quality never leaves our sight.

• Enzymatic seaweed extract (liquid) — the flagship product, straight from the hydrolysis line
• AlgaPep powder — the same enzymatic science in a fully water-soluble powder; potassium-free by process design, with customs classification (HS 31010090) already confirmed for normal export
• Alginate oligosaccharide (AOS) — a new-type fertilizer synergist cut by our own alginate lyase
• Chitosan oligosaccharide (COS) — fully water-soluble, independently verified, known as a plant vaccine
• Protein hydrolysates — chicken-derived peptides
Every formula MacroAlga releases passes three stages of verification: laboratory screening, climate-chamber trials, and field demonstrations. Science-rooted, data-driven, crop-proven — samples and full bioassay reports will be available on site at Booth D20.
As growers across North America seek to enhance crop quality and reduce dependence on conventional inputs, biostimulants play an increasingly central role in sustainable intensification. MacroAlga’s pure enzymatic route — nothing added but enzymes — offers formulators and distributors a differentiated raw-material partner backed by real manufacturing expertise and scientific trial data. Visitors to Booth D20 will see why the pure enzymatic approach fundamentally reshapes the understanding of seaweed-based products.
Our team will be at Booth D20 for all three days of the exhibition. Come and see why the ocean’s generosity deserves a gentler process — Pure Seaweed, Pure Power.
Enzymatic Seaweed Extract — The Flagship Product MacroAlga Brings to Sacramento 2026
About Qingdao MacroAlga
Qingdao MacroAlga Biotechnology Co., Ltd. is a leading biotechnology company specializing in the R&D, production, and application of core biostimulant raw materials, including enzymatically hydrolyzed seaweed, chitosan oligosaccharides, alginate oligosaccharides, and protein hydrolysates. Committed to science-based innovation and sustainable agriculture, MacroAlga serves growers and partners worldwide with high-performance, eco-friendly solutions.
Media Contact: info@macroalga.com
Website: www.macroalga.com